HH
ACAD icon

HWG Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History

HWG Holdings’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-460
Closed -$12.7K – 84
2017
Q4 		$14K Hold
460
– – 0.01% 77
2017
Q3 		$17K Sell
460
-5,001
-92% -$163K 0.01% 71
2017
Q2 		$152K Sell
5,461
-95,533
-95% -$2.85M 0.11% 34
2017
Q1 		$3.47M Buy
+100,994
New +$3.56M 4.38% 8
2016
Q4 		– Sell
-233,772
Closed -$7.44M – 16
2016
Q3 		$7.44M Sell
233,772
-55,608
-19% -$1.89M 7.81% 2
2016
Q2 		$9.39M Buy
289,380
+56,834
+24% +$1.9M 8.72% 2
2016
Q1 		$6.5M Buy
232,546
+146,002
+169% +$3.18M 5.82% 4
2015
Q4 		$3.08M Buy
+86,544
New +$3.05M 3.14% 16
2015
Q3 		– Sell
-64,566
Closed -$2.57M – 4
2015
Q2 		$2.57M Buy
+64,566
New +$2.5M 2.71% 15
2015
Q1 		– Sell
-96,959
Closed -$3.08M – 21
2014
Q4 		$3.08M Sell
96,959
-116,469
-55% -$3.3M 2.19% 18
2014
Q3 		$5.28M Buy
213,428
+150,808
+241% +$3.53M 4.24% 6
2014
Q2 		$1.42M Sell
62,620
-363,709
-85% -$7.59M 1.08% 28
2014
Q1 		$10.4M Sell
426,329
-214,202
-33% -$5.42M 9.43% 2
2013
Q4 		$16M Buy
+640,531
New +$15.1M 10.33% 2

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

HWG Holdings's ACAD Position: Q1 2018 in Review

HWG Holdings sold out of Acadia Pharmaceuticals (ACAD) in Q1 2018, closing a stake of 460 shares — an estimated $12.7K sold.

HWG Holdings first reported a position in ACAD in Q4 2013 and held it in 14 quarters. The position peaked at $16M in Q4 2013. 196 funds tracked by Wall St. Rank hold ACAD as of Q1 2018.

  • HWG Holdings reported no remaining Acadia Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • HWG Holdings sold 460 Acadia Pharmaceuticals shares in Q1 2018, an estimated $12.7K.
  • HWG Holdings first reported a position in Acadia Pharmaceuticals in Q4 2013 and held it in 14 quarters.
  • HWG Holdings's Acadia Pharmaceuticals position peaked at $16M in Q4 2013.
  • 196 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2018.

Based on HWG Holdings's 13F filing for Q1 2018, filed 27 Apr 2018.